Statistics
Publications
4
Citations
679
H-Index
4
Active since
2018
E. Hitt Nichols is an author at National Cancer Institute specializing in durvalumab therapy, olaparib therapy, and oncology.
Publications per year
2018–2020
4
4
Fatima Karzai, David James VanderWeele, Ravi A. Madan et al. · Journal for ImmunoTherapy of Cancer · 2018 · 312 citations · Full text
Medicine, Oncology, Pharmacology +17
Alexandra S. Zimmer, E. Hitt Nichols, Ashley Cimino‐Mathews et al. · Journal for ImmunoTherapy of Cancer · 2019 · 112 citations · Full text
Medicine, Oncology, Pharmacology +17
1–4 of 4